与invadopodia相关的Thrombospondin-1有助于治疗后在质母细胞瘤细胞中产生侵入性反应
Clarissa A Whitehead1, Andrew P Morokoff2, Andrew H Kaye3
1Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
Experimental cell research
|August 17, 2023
概括
放射和泰莫索洛米德治疗后,质母细胞瘤细胞变得更具入侵性. 血栓蛋白-1 (THBS1) 通过支持invadopodia来驱动这种入侵,提供了一个潜在的治疗目标.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 分子医学是分子医学.
背景情况:
- 质母细胞瘤 (GBM) 具有高度的侵入性,使治疗复杂化并导致复发.
- 标准放射治疗 (RT) 和铁胺 (TMZ) 治疗可以悖论地增强GBM细胞入侵.
- 了解治疗后的GBM细胞入侵机制对于开发有效疗法至关重要.
研究的目的:
- 在RT/TMZ治疗后,确定参与增强质母细胞瘤细胞入侵的基因.
- 为了研究血栓蛋白-1 (THBS1) 在GBM细胞入侵和入侵形成中的作用.
主要方法:
- 利用纳米链癌症进展基因表达面板来分析GBM细胞中的基因表达.
- 采用免疫光染色来定位THBS1在GBM细胞内.
- 评估了THBS1操纵 (过度表达和沉默) 后的GBM细胞迁移和MMP-2分泌.
主要成果:
- 已确定Thrombospondin-1 (THBS1) 是一种在RT/TMZ治疗后的GBM细胞上调调的亲侵入性基因.
- THBS1局部化到GBM细胞表面的矩阵降解的侵入物.
- 过度表达THBS1增强了GBM细胞迁移和MMP-2分泌;沉默THBS1减少了这些效应.
结论:
- THBS1与GBM细胞中的入侵有关,并在RT/TMZ治疗后导致入侵.
- THBS1很可能通过入侵介导GBM细胞入侵.
- 准THBS1介导的入侵活动代表了质母细胞瘤的潜在治疗策略.
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K


